EzySpot

Similar stories

Asia and North America Cervical Cancer Screening Market & Patients 3 years 35 weeks ago

Renub Research has announced its recent publication on “Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast”. The report gives a comprehensive picture of Global Cervical Cancer Screening Market with available diagnostic test pursued by developed, developing and under-privilege countries. In addition volume of patients diagnosed with cervical cancer and their mortality rate is also mentioned in this report. As of now cervical cancer cases is rising globally, Asia and North America both have reported more than 90 Million cervical cancer cases for the year 2016.

Worldwide Cervical Cancer HPV DNA Test (Screening) Market & Forecast 3 years 28 weeks ago

Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.

Europe Breast Cancer Ultrasound Screening Market & Forecast 3 years 30 weeks ago

Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 8 countries: United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland.
Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future. Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs.

Global Cervical Cancer Screening Market & Patients 2 years 33 weeks ago

Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human Papillomavirus (HPV) Virus. Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market.

Global Cervical Cancer Screening Market & Forecast 3 years 23 weeks ago

One of the most widespread cancer diseases in Women globally is Cervical Cancer. Cervical cancer is a disease with the long hidden era, early on recognition and care of precancerous lesions were extremely effective in women who often take screening tests. Mostly in many incidences, the disease is recognized as Human Papilloma Virus (HPV) infection. But in many developed nations, the death rate because of cervical cancer screening has fallen down. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020.

Asia Cervical Cancer Diagnostic Market Outlook 2 years 30 weeks ago

Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. Cervical cancer test market in Asian region is growing and expected to cross over 1,000 million dollars by 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China.

Global Breast Cancer MRI Screening Market Forecast 2 years 21 weeks ago

Breast Cancer Screening Market is projected to reach US$ 21 Billion by the end of year 2024. Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway, Switzerland, India, China, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand)” provides a detailed and comprehensive insight of the Breast Cancer Screening Market.